The inclusion

of MAP-specific click here genes in these deleted regions is an important observation as these genes could provide the basis for differentiating infected from vaccinated animals (DIVA). Indeed, the deleted region vGI-19 contains part of the 38 kb pathogenicity island described by Stratmann et al. (2004) [30] which contains genes encoding a number of antigens with diagnostic potential [31]. Both deleted regions vGI-19 and vGI-20 contain genes potentially involved in virulence and pathogenesis (Table  1) and their deletion could therefore have a profound effect on the virulence of these strains. In this study we demonstrated using a mouse model that both vaccine strains 2eUK2001 and IIUK2001 were attenuated with respect to a wild type MAP strain. In addition, vaccine strain MAPK Inhibitor Library cost IIUK2000 and IIUK2001 were found to contain a large 41 ORF tandem duplication (vGI-21) which includes copies

of benzoate and lipid metabolic pathways. Vaccine strain 2eUK2000 comes from the same stock as 2eUK2001 and was maintained at the VLA, UK for over 50 years on a mineral deficient medium (Watson Reid ‘A’ block) whilst vaccine strain IIUK2000 was not. We suggest that the vGI-21 duplication in vaccine strain IIUK2000 was selected by these differences in media and fixed into the genome to compensate in vitro for the deletion of lipid biosynthesis and carbon usage repertoires, removed by the vGI-20 deletion. The large deletion vGI-19 present in vaccine strain 316FNOR1960 was not present in any of the other 316 F strains including an early low passage lineage (316FCYP1966) and a more recent isolate (316 F2001)

shown to GPX6 be significantly attenuated in our virulence studies. Notably, part of vGI-19 is also present in the same gene order within the related MAH104 genome (GenBank reference CP000479). Together these suggest that any ancestral precursor and therefore the original 316 F strain would be unlikely to be missing vGI-19. We hypothesise that the vGI-19 deletion appeared in the 316FNOR1960 strain some point after its acquisition and transfer to Norway in 1960 from the VLA, UK. This strain is recorded as having been maintained, uniquely on Dubos medium with added pyruvate [15] and we hypothesise that this medium was at some point selective. This is supported by the vGI-19 deletion in this strain including gene homologues of glyoxylate enzymes associated with pyruvate metabolism [32]. This strain previously has been used successfully as a live vaccine suggesting that it is attenuated. The knockout of the glyoxylate shunt could significantly affect the strain’s ability to control anaerobic respiration [33] and intracellular persistence [34], which may indicate that attenuation in this strain may be related to this loss.